April 03, 2020

To, The Manager Listing Department, The National Stock Exchange of India Limited Exchange Plaza,

Bandra Kurla Complex,

Bandra (E), Mumbai – 400051

Dear Sir/Madam,

Sub: Disclosure under Regulation 30(1), 30(2) and 31(4) of SEBI (Substantial Acquisition of Shares and

Takeovers) Regulations, 2011 for the year ended on March 31, 2020

In accordance with the provisions of Regulation 30(1), 30(2) and 31(4) of SEBI Substantial Acquisition of

Shares and Takeovers) Regulations, 2011, the Company is in receipt of disclosure from Promoters

together with the persons acting in concert.

A disclosure received from Promoters together with the persons acting in concert is enclosed herewith

for your ready reference.

Kindly take the same on your record and oblige.

Thanking you,

Yours faithfully,

For Zota Health Care Limited

Ashvin Variya

(Company Secretary & Compliance Officer)

Place: Surat

Encl: a/a

Registered Office:

Zota House, 2/896, Hira Modi Street, Sagrampura, Surat-395002 Ph: +91 261 2331601 Email: info@zotahealthcare.com Web: www.zotahealthcare.com

CIN: L24231GJ2000PLC038352